Related Experiment Videos
Leiomyosarcoma of the uterus
American Journal of Obstetrics and Gynecology
|December 1, 1982
Summary
This study on uterine leiomyosarcoma found a 73% 5-year survival rate. Key favorable factors for uterine cancer prognosis include premenopausal status and low tumor mitotic count.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
Background:
- Uterine leiomyosarcoma is a rare and aggressive uterine malignancy.
- Accurate prognostic factors are crucial for patient management and treatment strategies.
Purpose of the Study:
- To review a series of uterine leiomyosarcoma cases.
- To identify prognostic factors influencing patient survival.
- To discuss management of special cases and differentiate primary vs. secondary leiomyosarcoma.
Main Methods:
- Retrospective review of 43 uterine leiomyosarcoma cases.
- Follow-up data collected for 41 patients (≥2 years).
- Analysis of prognostic indicators including patient status, tumor characteristics, and treatment modalities.
Main Results:
- Overall 5-year survival rate was 73%.
- Favorable prognostic indicators identified: premenopausal status, tumor confinement within a myoma, low mitotic count (<4/hpf), absence of necrosis, and adjacent hyalinization.
- Survival differences noted between primary myosarcoma and lesions arising in a leiomyoma.
Conclusions:
- Premenopausal status, tumor confinement, and low mitotic count are significant favorable prognostic factors for uterine leiomyosarcoma.
- Management of uterine leiomyosarcoma requires careful consideration of prognostic indicators and tumor origin.